|

Immunotherapy (Camrelizumab) Clinical Trials

1 actively recruiting trial

Also known as: Chemotheray (CAPOX or mFOLFOX6)

Top Sponsors

  • Beijing Chao Yang Hospital1

Indications

  • Obstruction1
  • Stent1
  • Neoadjuvant Chemotherapy1
  • Immunotherapy1
  • Colorectal Cancer1

Other1 trial

Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.